Story Stocks^®

DocuSign (DOCU +1%) is trading modestly higher following its Q4 (Jan) report, as the company delivered a solid EPS beat alongside generally better-than-expected guidance. While the magnitude of the revenue and EPS upside was fairly typical, guidance for Q1 (Apr) and FY27 stood out as particularly strong. The company also boosted its stock repurchase program by $2 bln.

• Revenue and EPS topped expectations, with upside roughly in line with recent quarters, albeit slightly more modest.
• Billings grew 10% yr/yr to $1.0 bln, exceeding prior guidance of $992-1,002 mln and accelerating from +8% in Q3; this marks the first time billings surpassed $1 bln. This will be the final quarter DOCU reports billings, transitioning instead to ARR and IAM as a percentage of ARR.
• FY26 ARR grew 8% yr/yr to nearly $3.3 bln, in line with FY25 growth; FY27 ARR will accelerate slightly to +8.25-8.75%.
• IAM (Intelligent Agreement Management) continues to gain traction, surpassing $350 mln in ARR just 18 months after launch, with strong retention and expansion trends.
• Non-GAAP operating margin improved to 29.5% from 28.8% yr/yr and above prior guidance; FY27 margins are expected to remain around FY26's 30.1% despite increased R&D investment.

Briefing.com Analyst Insight:

DocuSign delivered a solid quarter highlighted by steady execution and encouraging forward guidance, particularly around ARR growth and margins. The continued traction of its IAM platform is central to the long-term story, as it expands DOCU beyond its legacy e-signature roots into a more comprehensive agreement management ecosystem. Early adoption trends—already generating over $350 mln in ARR—suggest IAM is resonating with customers and helping drive bookings and retention improvements.

At the same time, overall ARR growth remains in the high-single-digit range, reflecting a still-maturing growth profile. Management's decision to discontinue billings in favor of ARR and IAM metrics should provide clearer visibility into this transition, but may reduce some near-term comparability for investors. Margin performance remains a key positive, with DOCU demonstrating the ability to sustain near-30% operating margins even while increasing investment in innovation. Combined with a strong balance sheet and stepped-up buybacks, management is signaling confidence in both the business trajectory and valuation.